Neuroinflammation in Alzheimer's Disease and Major Depression

Biological Psychiatry

Volumn 67, Issue 6, 2010, Pages 503-504

  Dobos, Nikoletta ^a   Korf, Jakob ^b   Luiten, Paul G M ^a,b   Eisel, Ulrich L M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BECK DEPRESSION INVENTORY; BRAIN CORTEX; BRAIN REGION; COGNITION; DISEASE COURSE; EXCITOTOXICITY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HIPPOCAMPUS; HISTOPATHOLOGIC SKIN REACTION; HOMEOSTASIS; IMMUNE SYSTEM; INNATE IMMUNITY; MAJOR DEPRESSION; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

EID: 76849113421     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.01.023     Document Type: Note

References (10)

1. Kannan S., Balakrishnan B., Muzik O., Romero R., and Chugani D. Positron emission tomography imaging of neuroinflammation. J Child Neurol 9 (2009) 1190-1199
2. Banks W.A. Blood-brain barrier transport of cytokines: A mechanism for neuropathology. Curr Pharm Des 8 (2005) 973-984
3. Marchetti L., Klein M., Schlett K., Pfizenmaier K., and Eisel U.L. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-d-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem 31 (2004) 32869-32881
4. O'Connor J.C., André C., Wang Y., Lawson M.A., Szegedi S.S., Lestage J., et al. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 13 (2009) 4200-4209
5. Capuron L., Ravaud A., Gualde N., Bosmans E., Dantzer R., Maes M., and Neveu P.J. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 8 (2001) 797-808
6. Goeb J.L., Even C., Nicolas G., Gohier B., Dubas F., and Garré J.B. Psychiatric side effects of interferon-beta in multiple sclerosis. Eur Psychiatry 3 (2006) 186-193
7. Su K.P., Huang S.Y., Peng C.Y., Lai H.C., Huang C.L., Chen Y.C., et al. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol Psychiatry 67 (2009) 550-557
8. Baune B.T., Dannlowski U., Domschke K., Janssen D.G., Jordan M.A., Ohrmann P., et al. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry 67 (2009) 543-549
9. Russo S., Kema I.P., Bosker F., Haavik J., and Korf J. Tryptophan as an evolutionarily conserved signal to brain serotonin: Molecular evidence and psychiatric implications. World J Biol Psychiatry 10 (2009) 258-268
10. Chavant F., Deguil J., Pain S., Ingrand I., Milin S., Fauconneau B., et al. Imipramine, in part through TNF alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease. J Pharmacol Exp Ther 332 (2010) 505-514